Reply: Mesenchymal stromal (stem) cell therapy: an emerging immunomodulatory strategy for the adjunctive treatment of sepsis.
1 Radboud University Nijmegen Medical Centre Nijmegen, the Netherlands.
Matthijs
M
Kox
Peter
P
Pickkers
D006801:Humans; D007114:Immunization; D007165:Immunosuppression Therapy; D018805:Sepsis / Q000188:drug therapy*